NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

AIDS Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



AIDS Therapies



"Loss of Cytomegalovirus (CMV) Viraemia Following Highly Active Antiretroviral Therapy in the Absence of Specific Anti-CMV Therapy."



August 23rd, 1999

According to the authors' abstract of an article published in AIDS, "Objective: To determine the effect of highly active antiretroviral therapy (HAART) on cytomegalovirus (CMV) viraemia and retinitis in patients at high risk of disease. Design: Sixteen patients with CMV viraemia, but no evidence of end organ disease at the time of first receipt of HAART including a protease inhibitor, were studied. No patient had ever received specific anti-CMV therapy. Methods: CMV load in blood was measured using quantitative competitive PCR at baseline and for a median follow-up of 21 months. Regular ophthalmological screening for retinitis was conducted throughout the...


Source: AIDS Weekly (1999-08-23)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login